United States

BioDelivery Sciences International Inc (BDSI.OQ)

BDSI.OQ on NASDAQ Stock Exchange Capital Market

4:00pm EDT
Change (% chg)

$0.20 (+9.09%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BDSI.OQ


BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products... (more)


Beta: 1.20
Market Cap(Mil.): $121.72
Shares Outstanding(Mil.): 55.33
Dividend: --
Yield (%): --


  BDSI.OQ Industry Sector
P/E (TTM): -- 14.31 17.43
EPS (TTM): -0.03 -- --
ROI: -0.12 -7.26 -5.41
ROE: -0.28 -6.76 -4.69

BRIEF-Biodelivery Sciences Q1 earnings per share $0.87

* Biodelivery Sciences International Inc - net revenue for Q1 ended March 31, 2017, was approximately $29.5 million.

May 15 2017

BRIEF-Biodelivery Sciences International files for non-timely 10-Q - SEC Filing

* Biodelivery Sciences International Inc says requires up to five additional days to file form 10-Q for the fiscal quarter ended March 31, 2017

May 10 2017

BRIEF-BioDelivery Sciences announces approval of BUNAVAIL

* Biodelivery sciences announces the approval of bunavail® for induction of buprenorphine treatment for opioid dependence

May 02 2017

BRIEF-Biodelivery Sciences announces the granting of two new patents

March 31 Biodelivery Sciences International Inc :

Mar 31 2017

BRIEF-BioDelivery Sciences Q4 loss per share $0.29

* Biodelivery sciences provides corporate update and reports fourth quarter and full-year 2016 financial results

Mar 17 2017

BRIEF-Biodelivery Sciences secures debt financing with CRG

* Biodelivery Sciences International - entered into a senior credit facility with affiliates of CRG LP to retire existing credit facility

Feb 23 2017

BRIEF-Stonepine Capital Management reports a 6 pct passive stake in Biodelivery Sciences International as of Jan 3, 2017

* Stonepine Capital Management LLC reports a 6 percent passive stake in Biodelivery Sciences International Inc as of Jan 3, 2017 - SEC filing Source text: (http://bit.ly/2iR1ESL) Further company coverage:

Jan 13 2017

BRIEF-BioDelivery Sciences International closed on deals contemplated by termination agreement

* Biodelivery sciences international-closed on deals contemplated by termination agreement, dated dec. 7, 2016 by and between co, its units - sec filing Source text (http://bit.ly/2ian7Vz) Further company coverage:

Jan 09 2017

More From Around the Web

Earnings vs. Estimates